Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis: Guidance for Industry

Issue Date: May 9, 2019
Issued by: Center for Biologics Evaluation and Research
Topic(s): Blood, Blood Products
Status: Final

Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis: Guidance for Industry

This guidance finalizes the draft guidance of the same title dated July 2018.

Download the Guidance Document

webmaster2026-08-05T19:03:02+00:00

ABOUT US

Avance Biosciences is a leading Contract Research Organization (CRO) and Contract Testing Organization (CTO) providing CGMP and GLP-compliant analytical and bioanalytical services to support drug development. From early discovery through clinical development and commercialization, we provide CGMP and GLP-compliant services tailored to your therapeutic modality and regulatory needs.